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ENHANCING DIAGNOSTIC STRATEGY OF RESPIRATORY VIRUSES IN THE 
PEDIATRIC POPULATION USING MACHINE LEARNING AND TEXT MINING 
 
Mark Mai, Michael Krauthammer. Department of Pathology Informatics, Yale University 
School of Medicine, New Haven, CT. 
 
Despite pressure from the federal government for US hospitals to adopt electronic 
medical records systems (EMR), the benefits of adopting such systems have not been 
fully realized.  One proposed advantage of EMRs involves secondary use, in which 
personal health information is used for purposes other than direct health care delivery, 
particularly quality improvement.  We sought to determine whether information recorded 
in the EMR could improve diagnostic pathways used to diagnose respiratory viruses in 
children, the most common etiology of diagnoses in the pediatric population.  These tests 
potentially represent a source of unnecessary testing. We performed a retrospective 
observational study analyzing pediatric inpatients receiving respiratory virus testing at 
Yale-New Haven Children’s Hospital between March 2010 to March 2012.  Billing data 
(age, gender, season), laboratory data (sample adequacy, results), and clinical documents 
were gathered.  We used MetaMap, a program distributed by the National Library of 
Medicine, to identify phrases denoting symptoms and diseases in the admission notes of 
patients.  Identified concepts were added as additional variables to be modeled.  Weka, 
another freely available software that allows for easy incorporation of machine learning 
algorithms, was used to derive models based on the C4.5 decision tree algorithm that aim 
to predict whether or not patients should be tested.  Orders for pediatric patients 
accounted for 26.3% of all respiratory virus test orders placed during this time.  Negative 
test results accounted for 69.5% of all tests ordered during the study period.  The lengths 
of stay for all viral diagnoses were not statistically different.  Models based on age, 
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gender and season alone, were predictive for influenza (AUC 0.743, SE = 0.126), 
parainfluenza (AUC 0.686, SE = 0.078), RSV (AUC 0.658, SE = 0.048), and hMPV 
(AUC 0.713, SE = 0.143).  Using MetaMap terms alone, only the model for RSV showed 
discriminatory ability (AUC 0.661, SE = 0.048).  When basic variables were used in 
conjunction with MetaMap concepts, only the model for RSV showed improved 
performance (AUC 0.722, SE = 0.051) in comparison to both the basic and MetaMap 
models.  Respiratory virus tests for general admission pediatric inpatients are ordered 
year-round and are mostly negative.  Using models based on decision tree learning, our 
results showed that test volume could be reduced by about 20-50% for certain tests, as 
measured by model specificity.  Furthermore, clinical concepts obtained via text mining 
in conjunction with basic variables improved prediction of RSV test results.  The tradeoff 
between the false negative rates required to achieve any substantive specificity may be 
mitigated by our finding that hospital stays were nearly identical, regardless of the 
diagnostic outcome.  These results support the use of EMR data for the auditing of and 
improvement of laboratory utilization.  In addition, the improvement of predictive 
modeling for RSV with a simple implementation of text mining support the idea that 
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The Costs of Testing 
While rates of health care spending seem to have stabilized compared to the 
growth of the gross domestic product in the United States, more effective and flexible 
approaches to cost control have remained at the forefront of national discussion (1–4).  
Of the various strategies proposed to reduce costs, identifying areas of waste is an 
important step (5).  Six categories were listed by the Institute of Medicine as key sources 
of spending waste, which include unnecessary services, inefficient delivery of services, 
excess administrative costs, overcharged prices, missed prevention opportunities, and 
fraud.  Of the $2.5 trillion spent on healthcare in the United States in 2009, the excess 
spending totaled an estimated $750 billion with unnecessary services leading these 
categories at $210 billion (5).  This group of expenditures also includes unnecessary 
pathology and laboratory tests, which as a whole constitute about 4% of annual 
healthcare costs (5, 6).   
Improved utilization of laboratory tests represents an area with the potential to 
substantially impact healthcare spending in the United States.  Despite the relatively 
small fraction of healthcare spending comprised by laboratory spending, physicians 
routinely base their decision making on information gleaned from laboratory data (6).  
Some have estimated that 60-80% of critical medical decisions, such as admissions, 
treatments, and discharges, are influenced by laboratory data, though this frequently cited 
number has been recently called into question (7–9).  One prospective study looking at 
the impact of rapid diagnosis of influenza, found that emergency department (ED) 
physicians aware of a positive influenza result were significantly less likely to order 
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additional tests, particularly complete blood cell counts and blood cultures (p < 0.001).  
In addition, there was a reduction in the number of antibiotic prescriptions, in the mean 
charge per patient, and time to discharge for patients whose physicians knew of a positive 
test result.  Physicians who were aware of a negative rapid influenza test result were not 
significantly different from physicians who were unaware of the test result, suggesting 
that knowledge of a test result affects management when the result is abnormal (10). 
Although the role of laboratory tests is extremely important in the clinical setting, 
various behaviors likely contribute to excess spending in this area.  From the laboratory 
point of view, unrequested tests (reflex testing), slow turnaround of results, and collection 
of incorrect or inadequate samples may contribute to additional test ordering (11).  Other 
studies have linked the ubiquity of repetitive test ordering to systemic variables such as 
daily variations in test ordering and provider continuity (12–14).  A systematic review by 
Sood et al. identified multiple physician determinants for non-evidence based test 
ordering practices (15).  One group of factors included those that are non-modifiable, like 
practice location, age, sex, and specialization of the physician.  Modifiable factors 
included physicians’ experience or knowledge, fear of litigation, lack of experience, 
belief system, lack of knowledge of test costs and feedback.  The modifiable factors are 
perhaps the most important, as addressing these areas may have a considerable impact on 
the number of unwarranted tests performed.  
Appropriate utilization of tests, or demand management, aims not only to reduce 
test volume, but also to ensure appropriate requests.  This implies that references or 
guidelines exist for what may be deemed appropriate and inappropriate (11).  One such 
reference comes in the form of clinical prediction rules (CPRs).  CPRs are clinical 
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models comprised of variables from the history, physical examination, and basic 
diagnostic tests that provide a probability of a diagnostic outcome.  CPRs are designed to 
quantify the amount of uncertainty present in medical decision making (16).  In this way, 
physicians may employ clinical information to quantitatively risk stratify patients or to 
assess the value of additional steps in management.  One of the most well-known 
examples incorporated clinical assessment with a less costly screening test to diagnose 
deep venous thromboses, demonstrating the value of clinical diagnosis in an age of 
increasing reliance on technology and testing (17).  Known as the Wells’ criteria, this 
CPR has been further validated in multiple studies, although widespread adoption of the 
algorithm is scattershot (18).  Since the publication of the Wells’ criteria, hundreds of 
CPRs for numerous applications have been developed (19, 20).  Independent studies have 
found that the use of Wells’ crteria for pulmonary embolism could reduce the number of 
computed tomographic pulmonary angiography procedures done by around 10-25% (21, 
22).  By helping physicians reduce the amount of diagnostic uncertainty, CPRs encourage 
a more efficient diagnostic process, and thus a reduction in the number of unnecessary 
tests that are performed.  
Respiratory Virus Testing in Children 
Upper respiratory infections comprise one of the most common emergency 
department diagnoses in the pediatric population (23).  Respiratory illnesses account for a 
large percentage of pediatric emergency department visits each year - up to 25% during 
influenza seasons (24).  A large variety of viruses may cause respiratory symptoms, but 
only a handful of viruses can be diagnostically confirmed (25–30).  In the majority of 
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children, a respiratory viral infection is mild and considered self-limiting with adequate 
supportive care (31–33).  
Nevertheless, routine testing for specific viruses (adenovirus, influenza A/B, 
parainfluenza 1-3, and respiratory syncytial virus) in defined populations is likely 
warranted, as certain subpopulations of pediatric patients are at greater risk for 
complications secondary to these infections (27, 33–35).  Adenovirus infections remain a 
large concern for pediatric patients who have undergone transplantation, as the incidence 
of infection is about 2.5-fold greater than adult populations (36).  Positive test results in 
this population may allow physicians to discontinue antibiotics or even consider 
treatment with cidofovir in cases of severe infection (37, 38).  For cases of seasonal 
influenza, the American Academy of Pediatrics recommends that treatment be initiated 
for any child hospitalized with presumed influenza or complicated illness, as well as for 
children one year of age (39).  Furthermore, early detection of a seasonal influenza 
infection within 48 hours of symptom onset may prompt treatment with neuraminidase 
inhibitors in children (40).  Although evidence is lacking, some institutions have 
considered treating parainfluenza in immunocompromised patients with ribavirin and or 
intravenous immunoglobulin (41).  Routine testing might also make some economical 
sense, as it may decrease antibiotic usage, shorten the length of hospitalization, and 
reduce the number of additional tests ordered for patients that are positive for these 
viruses (26, 42–49). 
 The evidence for viral testing as a screening tool in otherwise healthy patients 
presenting with acute respiratory illness is equivocal.  A recent meta-analysis by Doan et 
al. found that in the pediatric emergency room setting, rapid viral testing for acute febrile 
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respiratory illness did not lead to reduced use of antibiotics, shorter ED stay, or change in 
blood or urine testing, although those tested had lower rates of chest X-rays (RR 0.77 
95% CI 0.65 to 0.91) (50).  Some institutions use viral testing primarily to allocate newly 
admitted patients to shared rooms with patients who have a similar viral diagnosis, 
otherwise known as “cohorting.”  Krasinski et al. found that screening for RSV at 
admission and subsequent cohorting reduced the RSV nosocomial rate from 7.17 cases 
per 1000 patient days to less than 1 (51).  A recent study from the Netherlands further 
evaluated this claim in a prospective observational cohort study in pediatric patients 
hospitalized due to bronchiolitis (52).  The study found that while over half of the 
patients shared a room with a patient infected with a different virus (54.1%), only two 
patients (4.2%) acquired a co-infection during admission.  In addition, these co-infected 
patients did not share a room with another patient during their stay.  These data suggest 
that using viral testing for cohorting purposes may not be rooted in the best available 
evidence.  As further studies are needed to determine the effect of cohorting, proper 
contact precautions and hand washing may be the most effective measures in preventing 
nosocomial infections (53, 54). 
Having largely replaced detection by viral culture, rapid viral testing has now 
become a standard diagnostic tool for respiratory infections.  Methods for rapid detection 
often entail lateral flow immunochromatography (rapid flu tests), a type of antibody 
binding, direct fluorescent antigen (DFA) testing, and viral isolation by nucleic acids via 
polymerase chain reaction (PCR) (55–57).  While both DFA and PCR have high 
specificity, tests based on DFA are less sensitive (25, 58).  As DFA is a more cost-
effective test than PCR (59), some institutions have instituted a schema where DFA is 
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used as a first-line “screening test” for respiratory viruses (57, 58, 60). In these 
institutions, PCR testing is only done for patients with negative DFA test results.  
Although this “stacked” testing approach does allow for some cost-saving by eliminating 
the need for expensive PCR testing for patients with positive DFA results, it does not 
adequately address the issue that the vast majority of pediatric ER visits for respiratory 
illness produce negative test results for all viruses tested (25).  Thus, in many cases, 
patients receive two types of testing for the same viral agent.  
 Diagnosis of respiratory viruses likely represents a source of inappropriate 
utilization.  The available evidence has not backed the routine use of laboratory testing of 
respiratory viruses.  The American Academy of Pediatrics published a clinical practice 
guideline in 2006 on the diagnosis and management of bronchiolitis, which included the 
recommendation against routine diagnostic studies, in favor of the history and physical 
examination (61).  In spite of this, testing practices vary widely from institution to 
institution. 
The Use of Clinical Prediction Rules 
Clinical prediction rules for pediatric respiratory illnesses have been developed to 
help reduce the uncertainty, but these mostly focus on the risk of unfavorable outcomes 
due to RSV infection, like hospitalization or clinical deterioration.  A CPR developed by 
Rietveld et al. estimated the monthly risk of hospitalization due to RSV in young children 
(62).   The study found five clinical predictors: gender, gestational age, birth weight, 
presence of bronchopulmonary dysplasia and age.  By discriminating between high and 
low risk children, the study estimated that passive immunization for RSV could be 
reduced by 20%.  Another CPR based on data from a prospective birth cohort study, 
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determined the risk of RSV lower respiratory tract infection in healthy newborns (63).  
The CPR incorporated the birth history predictors of weight and month of birth, in 
addition to the social history components of day care attendance and/or siblings and 
parental education.  The model had an area under the receiving operating characteristic 
curve (AUC) of 0.72 (95% CI 0.64 to 0.80). Brooks et al. developed a prediction rule for 
point-of-care use that estimated the risk of deterioration in infants with and RSV 
infection (64).  Their model focused on more physiological parameters and found 
tachypnea and hypoxemia to be predictors with high specificity, >97% for each, and low 
sensitivity ≤ 30%.  The data suggested that the wide variability in clinical presentation 
limited the usefulness of these parameters. 
Determining the odds of a specific laboratory diagnosis for respiratory viruses has 
not been thoroughly explored in the literature.  Michiels et al. derived prediction rules for 
distinguishing between influenza and influenza-like illness in the primary care setting 
(65).  The study found that ruling out influenza using clinical and historical information 
is a more feasible approach than trying to rule it in.  During periods outside when 
influenza is not highly prevalent, the absence of a cough or fever is associated with a 14-
fold decrease in likelihood of influenza.  The presence of sick contacts, cough, 
expectoration, and fever during a period of an epidemic increases the likelihood by a 
factor of three.  Using similar clinical factors employed in clinical prediction rules, it may 
be possible to calculate the likelihood of being carrier for other viruses.  Potential 
predictors, such as the seasonality of the influenza, parainfluenza, and RSV viruses, 
meteorological parameters, and clinical features have been documented in the literature 
(66–71).  Little is known, however, about the ordering patterns of these tests and whether 
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test ordering is correctly aligned with seasonal prevalence. If satisfactory test 
performance characteristics (sensitivity and/or specificity) are met, clinical models may 
be viewed as diagnostic tests that do not add to the cost of a patient’s hospitalization and 
are useful for triaging patients with low or high likelihood of serious illness. 
As described by Wasson et al. in their seminal article, clinical prediction rules 
should adhere to strict methodological standards for use in clinical practice (16).  These 
include guidelines pertaining to the development of the CPR, like clearly defining the 
event to be predicted, as well as the predictive findings, and blinded assessment of 
outcome and prediction.  Other criteria relate to the communication and evaluation of the 
rule, like statement of the specific population that the rule may be applied to and a 
description of the mathematical technique employed.   By striving to meet all of the 
guidelines, researchers are able to ensure that the prediction rules are based on principles 
of sound study design and are generalizable. 
While CPRs are powerful tools that can supply physicians with point-of-care 
diagnostic and prognostic probabilities, which facilitate reductions in spending, the 
guidelines to the development, validation, and implementation of CPRs, fail to address 
barriers to their use in practice (72).  Katz offers multiple reasons for the underuse of 
prediction rules, including lack of validation and reproducibility, preference for one’s 
own judgment, and a time-consuming process (73).  Furthermore, the different types of 
CPRs - scoring by univariate analysis, models based on multivariate analysis, 
nomograms, artificial neural networks, and decision trees - requires that physicians be 
familiar with multiple models, as well as their advantages and disadvantages (19).  By 
definition, CPRs should contain at least three variables for prediction (16), with 
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additional variables usually resulting in better accuracy of a model.  Implementation of 
such models in practice are computationally heavy processes for physicians, whereas 
leveraging the computational power behind electronic medical records would likely 
improve upon and accelerate the process of building clinical models to reduce uncertainty 
(74–77).   
Practice Based Evidence from Electronic Medical Records 
The term “secondary use” of health data entails utilizing personal health 
information for purposes other than direct health care delivery (76).  The electronic 
medical record represents an underutilized source of information on the delivery and 
consumption of health services.  In their report Best Care at Lower Cost: The Path to 
Continuously Learning Health Care, the Institute of Medicine emphasized the 
importance of building such a digital infrastructure that supports the improvement of 
patient care both immediately at the time of delivery and for patients in the future (3).  
This perspective recognizes that areas for quality improvement in health care can already 
be found in the electronic medical record, but the system is lacking in the appropriate 
tools to identify and act on these areas.   
The derivation of clinical prediction rules might potentially benefit from advances 
in secondary use.  First, the EMR could help practitioners identify inefficient practices, 
like non-evidence-based laboratory testing, that are high volume and consume precious 
financial resources.  These practices could serve as foci for institutional quality 
improvement projects.  Second, the EMR could serve as an initial source of pre-existing 
data, prior to the much more costly expenses of performing the prospective studies that 
are required by the strict standards of developing CPRs.  Examples of such “practice-
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based” workflows are now beginning to unfold, as advances in health information 
technology, although thus far, efforts have not been focused prediction rules for disease. 
Studies incorporating electronic health information into clinically useful models 
have increased evidence for real-world application of secondary use.  Lependu et al. 
published novel methods that utilize the information contained in the free-text portion of 
clinical documents to improve pharmacovigilance (78, 79).  Specifically, their work 
identified both adverse drug events (AUC 75.3%), as well as drug-drug interactions 
(AUC 81.5%).  Had a continuously learning system been in place, six out of nine drugs in 
their reference set would have been detected on a time scale earlier than the official date.  
The Duke Enterprise Data Unified Content Explorer (DEDUCE) is an example of 
learning health system that serves as a portal for investigators to query their database 
containing millions of clinical records, obtain aggregate reports, and expedite cohort 
recruitment (80, 81).  The system further supports text mining and integration of clinical 
text with structured data.  Another study demonstrated that automatically extracted 
clinical elements could provide accurate real-time assessments of a patient’s physiologic 
status in a clinical setting.  The researchers focused on an algorithm based on 26 clinical 
variables, including vital signs, laboratory test results, cardiac monitoring, and nursing 
assessments, to automatically generate a score of a patient’s general condition, known as 
the Rothman index (RI).  They found that the earliest recorded RI stratified by scores 
were significantly correlated with total costs of hospitalization (p < 0.0001) and average 
lengths of stay (p<0.0001).  Furthermore, the average RI score was significantly 
correlated with measures, as well as the average number of complications (p < 0.00001) 
(82).   
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The application of clinical prediction rules to laboratory testing may benefit from 
a similar approach.  A retrospective study by Cismondi et al. aimed to reduce 
unnecessary laboratory testing for patients with gastrointestinal bleeds in the intensive 
care unit setting (83).  Using vital signs data along with previous lab values, the study 
employed fuzzy modeling, a type of machine learning for nonlinear systems, to ascertain 
whether additional testing would lead to information gain for a given test.  Models were 
developed for eight blood tests chosen by expert consensus to be most important in the 
management of gastrointestinal bleed.  The researchers found that use of the models 
could reduce testing by 50% on average. Using these models, however, would have also 
led to an average false negative rate of 11.5% of tests that actually went unperformed, but 
would have resulted in information gain.  Particularly in the case of respiratory viruses, 
the development of a practice-based CPR might make sense.  Use of the electronic 
medical record would enhance the audit of test utilization to evaluate whether the current 
practice of physicians could actually be improved.  Furthermore, as geographic variation 
exists in tandem with seasonal variation of different viruses, an institutional based 
method might not be generalizable, but may have positive implications for the institution 
in question.  Furthermore, extraction of clinical concepts through automated text mining 
of clinical documents would allow for automated calculation of CPRs or other 
computational clinical models, relieving the practitioner to focus on clinical care, as 




Develop a clinical model using an optimal machine learning classifier that reduces the 
volume of respiratory virus tests without missing false negatives.  Hypothesis: That 
clinical features, such as season, age, and reported symptoms can be used to quantify the 
need for testing. 
A. Develop a simple clinical model based on billing data variables (season, age, and 
gender). 
B. Augment the simple clinical model with variables gathered from text mining of 




Patients and specimens 
This retrospective study was performed using protocols reviewed and approved 
by the Yale University Institutional Review Board.  Prior to data collection, discussions 
were held with practicing pediatric experts in hospitalist medicine, infectious disease, and 
emergency medicine regarding the volume of respiratory testing, the cost of testing, and 
the effect of test results on management.  Patients were selected from a database of 
patients who received respiratory virus laboratory testing.  The study population 
consisted of 11,476 hospitalized inpatients from which nasopharyngeal swabs were 
obtained from March 2010 to March 2012 at Yale New Haven Hospital (YNHH).  The 
following inclusion criteria were employed: adequate nasopharyngeal swab sample, 
inpatients 18 years old and younger, and test ordering within two days of admission.  
While the volume of respiratory virus testing is much higher in the adult population, 
pediatric patients were chosen for this study because at this particular institution, 
respiratory testing in the adult ED often is ordered prior to a physician seeing the patient, 
whereas in the pediatric ED, the patient is usually seen before the order is placed.  As a 
result, the HPIs written for adult patients might not contain the clinical rationale behind 
testing, since the physician taking care of a patient would not have been responsible for 
the order.   
The data were received in a Microsoft Access database, consisting of the 
following variables: MRN, Date of Birth, Billing Number, Order ID, Order Date, 
Admission Date, Discharge Date, Gender, Race, Patient Type, Specimen Quality, and 
Test Results.  The results for the following tests were included: Adenovirus DFA and 
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PCR, Influenza A/B DFA and PCR, Parainfluenza 1-3 DFA and PCR, Respiratory 
Syncytial Virus DFA and PCR, Human Metapneumovirus PCR, and Rhinovirus PCR.   
The following steps were used to de-identify the data.  Each patient was given 
randomly generated numeric key (Patient ID), which was stored in a master key file on an 
encrypted machine used solely for data de-identification and clinical note retrieval.  
Because each Billing Number is associated with a specific visit, we defined a variable for 
"Visit Number" for patients with multiple admissions, which stored whether the given set 
of test results were obtained during the patient’s first, second, third, etc visit of a given 
year.  In a similar fashion, some patients received nasopharyngeal swab testing more than 
once during their stay, and a new variable for "Order Number" was generated based on 
the Order ID and Order Date.  The season of testing was obtained from the Order Date.  
The age of each patient at the time of testing was calculated into a new variable.  The 
number of days from admission to the date of the order was also generated.  Length of 
stay was calculated for each patient, as the difference between the Admission Date and 
the Discharge Date.  The final resulting de-identified database contained the following 
variables: Patient ID, Visit Number, Order Number, Season, Age at Testing, Days until 
Order, Length of Stay, Gender, Patient Type, Specimen Quality, and Results for the 
following tests: Adenovirus DFA and PCR, Influenza A/B DFA and PCR, Parainfluenza 
1-3 DFA and PCR,  Respiratory Syncytial Virus DFA and PCR, Human 
Metapneumovirus PCR, and Rhinovirus PCR. 
Medical concept identification in notes. 
For each patient, the history and physical examination on admission was obtained 
by accessing Sunrise Clinical Manager on the encrypted machine.  A short program was 
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written in Java to parse the HPI from each note, regardless of the specific document 
template used.  These resulting sections were then de-identified and saved in text files, 
identified by the Patient ID, which had been randomly assigned in the previous de-
identification step. 
MetaMap 2013 was used to identify medical concepts in the HPI of each note.  
MetaMap 2013 is a program made available by the National Library of Medicine that 
allows users to map biomedical text to the Unified Medical Language System 
Metathesaurus (84, 85).  The program offers a high degree of configurability to users, 
allowing them to specify the semantic types of concepts to be mapped, set the minimum 
threshold for a mapping score, negate concepts, select specialized terminologies, and 
expand abbreviations, as well as many other options.  In addition, a Java application 
programming interface, or API, is also available for MetaMap, which permits users to 
query terms to be matched in MetaMap with specified options and tailored outputs.  The 
Java API was used to write a program that sent the parsed HPI portions to the MetaMap 
program for concept identification and exported the returned results into a spreadsheet 
containing the original phrase, the matched concept, and the concept type. 
The following options were used in MetaMap.  We limited the mapping of terms 
to the SNOMED CT terminology, considered to be the most comprehensive medical 
terminology available.  Furthermore, we limited the semantic types to “signs and 
symptoms” and “diseases and syndromes”, as we hypothesized that these factors would 
most likely be predictive for respiratory virus test results.  We also set MetaMap to utilize 
all derivational variants of a word identified in the HPI, as well as allow for concept gaps.  
MetaMap was also set to expand any acronyms and abbreviations that matched, as well 
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as output negated concepts with a prefix of “neg_concept”.  The identified concepts were 
stored as a string vector with concepts delimited by a non-letter character (exclamation 
point), which were used as delimiters for the tokenization process in the modeling 
software.  This string was then appended to the data of the corresponding Patient ID.   
Machine learning models 
The table, including each patient’s age, gender, season of testing, and string of 
mapped concepts, was imported into Weka for model development.  Weka is a freely 
available Java based implementation that houses numerous machine learning algorithms, 
as well as tools for data pre-processing, or “munging,” classification, clustering, 
association rules, attribute selection, and visualization - all steps employed in data mining 
projects.  For this thesis project, Weka version 3.7.9 was used specifically for select data 
munging steps, attribute selection, and classification model development (86). 
Following identification of UMLS Metathesaurus concepts by MetaMap, the data 
consisted of the following variables:  
● ID (independent variable) 
● Age (independent variable) 
● Gender (independent variable) 
● Season (independent variable) 
● String of MetaMap concepts (independent variable) 
● Viral diagnosis (dependent variable) 
 In order to prepare the data for model development, a number of filters within the 
Weka software were applied to the data.  First, we applied a filtered classifier that used a 
word tokenization process to convert the string of MetaMap concepts into a word vector, 
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which across all patients comprised a feature matrix.  To be included in the matrix, 
concepts had to be present in at least 10 notes.  This process resulted in the concepts 
featured as additional columns in the table, with 1 representing whether or not the 
concept was mentioned in a patient’s HPI and 0 representing the absence of the concept.  
Following this step, we performed attribute selection, otherwise known as feature 
selection, which determined the most relevant independent variables in the matrix, given 
the virus to be modeled.  In this step we employed information gain to evaluate the worth 
of an attribute.  As the information gain was automatically computed by the Weka toolkit, 
the mathematical background behind the technique is referenced elsewhere (87, 88).  
Attribute selection using information gain allowed us to efficiently shrink the number of 
variables to include in the model from over 400 to less than 20, depending on the virus 
we were modeling.  
 Following the application of these filters, the data were then in a format ready for 
modeling.  For this step, we used a cost sensitive classifier on top of other machine 
learning algorithms to deal with our unbalanced dataset (89).  Using this approach, we 
were able to overcome the fact that the number of negative cases greatly outnumbered the 
positive cases for any viral diagnosis.  Thus, by weighting against a particular outcome - 
in this case false negative results - the subsequent machine learning algorithm could train 
to discriminate what might actually constitute positive cases, instead of classifying all 
cases as negative, which would provide the best objective results for the model. 
 Finally, the decision tree learning algorithm, J48, was used to develop and 
evaluate each model via 10-fold cross-validation.  J48 is an open-source Java 
implementation of the C4.5 decision tree algorithm, which classifies instances by 
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iteratively adding nodes and branches that optimize the information gain at each step 
(90).  Cross-validation was chosen in order to minimize bias associated with differences 
that arise year to year.  To construct a receiver-operator characteristic (ROC) curve, we 
generated multiple sensitivities and specificities at various thresholds, which we set by 
varying the cost ratio between false negative to false positive cases for the cost sensitive 
classifier.  Formally, this technique is known as ROC instance-varying transformation, 
although will be referred to as ROC for the purposes of this thesis (91).  ROCIV takes 
into account that the cost associated with classification errors varies by situation.  
Following the iterative process of producing sensitivities and specificities at subsequent 
cost thresholds, these values were then used to construct receiver operator characteristic 
curves via the trapezoidal rule for each of the three models for each virus: basic, 
MetaMap-based, and combined.  The trapezoidal rule was defined as base*height/2. 
In order to calculate the standard error for each ROC curve, we used the equation 
below as published by Hanley and McNeil (92),    
SE	
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where A is the area under the curve, na is the number of abnormals, nn is the 
number of normals, Q1 is the probability that two randomly chosen abnormal results are 
both classified as abnormal compared to a random normal result, and Q2 is the 
probability that one randomly chosen abnormal result is classified as abnormal compared 









A pairwise Wilcoxon rank sum test was used to compare the lengths of stay for 
different viral diagnoses.  The pairwise.wilcoxon.test function in R was used to 
calculate whether or not the populations differed with respect to length of stay.  Because 
multiple comparisons were made, the Bonferroni correction was used to appropriately 
adjust the p-value. 
To determine the precision of the MetaMap software when run on the corpus of 
clinical notes, concepts identified by MetaMap were compared to the original text.  One 
hundred notes were randomly selected for review.  For each note, the identified concepts 
were reviewed and compared to the original utterance, which had been mapped.  Partial-
match precision was calculated by dividing the number of MetaMap matches (both partial 
and exact) by the total number of matches made by MetaMap in a fashion similar to Pratt 
and Yetisgen-Yildiz  (93).  A partial-match was defined as situations in which the 
identified MetaMap concept contained all the words expressed in the original phrase, but 
did not match the phrase exactly.  For example, when MetaMap identified the concept 
developmental language delay, whereas the original phrase was developmental delay, the 
label “partial-match” was assigned to this mapping.  Recall was not calculated because 
we were primarily interested in the concepts that MetaMap was actually able to identify 





From the period of March 2010 to March 2012, 18,947 nasopharyngeal swab 
orders were placed for 11,476 patients during 16,043 visits.  Figure 1 shows the 
subsequent sample sizes after applying exclusion criteria.  Orders for pediatric patients, 
who were not originally admitted to the neonatal intensive care unit, comprised 26.3% 
orders placed during this time.  This population of patients made up 27.9% of all patients 
tested.  In this sub-population, 58.3% of orders were performed on inpatient admissions, 
which encompassed 60.2% of pediatric patient types that were tested.  Of the tests that 
were ordered within 2 days of admission, 85.6% of specimens were of adequate sample 
quality to run the tests.  For the patient subset meeting these inclusion criteria, clinical 
notes were able to be obtained for 1,848 of these visits.  In total, orders for general 
admission pediatric inpatients accounted for 11.5% of all respiratory virus test orders 
placed during this time. 
Table 1 summarizes the basic clinical variables of gender, age, and season by 
etiology.  Negative test results accounted for 69.5% of all tests ordered during the study 
period.  Males comprised around half of each viral diagnosis except for adenovirus 
diagnoses of which males comprised 68.8%.  The mean age for all viral diagnoses was 
less than 5 years of age, except for positive cases of influenza, where the mean age of 
diagnosis was higher at 8.24.  It should be noted that the standard deviation for each of 
the mean ages was rather large.  One easily measured health outcome, median length of 
stay, was consistent across all diagnoses at less than 3 days except for human 
metapneumovirus infections (Figure 2).  The median duration of stay held true for both 
positive and negative cases alike at 2 days, even for patients in whom multiple viruses 
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were detected.  A pairwise Wilcoxon rank sum test showed no statistically significant 
difference in lengths of stay associated with different viral diagnoses. 
Both DFA and PCR panels were ordered throughout the period under study and 
showed similar patterns in peak months of test ordering (Figure 3).  During the study 
period, DFA panels (n = 2152) were ordered 3.9 times more often than PCR panels (n = 
550).  Figure 4 shows density plots of the positive laboratory tests aggregated by month 
during the study duration.  Adenovirus and rhinovirus were detected in all months with 
no clear pattern.  Cases of co-infection, influenza, hMPV, parainfluenza, and RSV 
demonstrated regular seasonal fluctuations.  The proportion co-infected cases were 
present at low rates during the entire year, but demonstrated peaks in the winter months 
of each year.  None of the cases of influenza occurred outside the winter or spring 
months.  Cases of hMPV have a similar distribution to influenza infections.  Positive 
parainfluenza test resulted largely occur during the late winter into the summer, although 
positive test results were seen throughout the year.  Cases of RSV arose primarily during 
the winter months, although the onset of the RSV season appeared to differ between the 
two years. 
Prior to building the models for each diagnosis using clinical variables, MetaMap 
variables, or both, we evaluated the performance of the MetaMap program in identifying 
concepts by calculating the partial-match precision across 100 randomly selected notes.  
The partial-match precision can be likened to the positive predictive value, in which we 
evaluated the concepts MetaMap identified against their original phrases.  The main 
author evaluated the MetaMap concepts in comparison to the original phrase.  As 
described in the methods section, partial-matches included cases where the MetaMap 
27 
concepts contained all of the words in the original phrase, but did not match exactly.  
Negative matches failed to meet these criteria.  Correct mappings were considered to be 
“true positive” cases in the equation, whereas incorrect mappings were “false positive” 
cases.  The partial-match precision was calculated to be 0.724 across this random sample.  
Recall (or sensitivity) was not calculated, as we were not interested in the 
comprehensiveness of MetaMap as a concept identifier, but rather in its accuracy. 
We initially developed models for the outcomes of DFA or PCR panels, as 
positive or negative. A positive DFA or PCR panel meant that at least one test on the 
panel returned positive.  Season, gender, and age were termed “basic clinical variables” 
to be used as the independent variables for inclusion in our initial modeling.  The results 
are depicted in Figure 5.  As can be seen, the models generated using these variables are 
both positively predictive, although to a very minimal extent with the AUC for all models 
falling < 0.65.  Our MetaMap model for the panels consisted of independent variables 
solely based on the concepts identified in the history of present illness (HPI) section of a 
patient’s admission note.  As with the basic clinical variables, MetaMap terms were 
predictive, but to a low degree, yielding low rates of sensitivity for varying cost 
thresholds.  When the MetaMap terms were used in conjunction with the basic clinical 
variables, the performance of the resulting model appeared to be slightly more robust in 
the case of DFA panel prediction, and remained low for PCR panels. 
We then used the same approach to model the test results for individual viruses, 
which is graphically displayed in Figure 6 and numerically shown in Table 2.  For each 
of the six viruses, modeling with basic clinical variables yielded models with predictive 
value. Discrimination of test results with basic variables were best with influenza, hMPV, 
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parainfluenza, and RSV, while adenovirus and rhinovirus models showed minimal 
predictive power.  The use of concepts identified by MetaMap as the sole independent 
variables for the models was non-predictive for any virus, except for RSV, where the 
MetaMap based model was nearly equally as predictive as the model based on clinical 
variables (AUC: 0.661 vs. 0.658, respectively).  In all cases except for RSV, models 
based on basic variables alone performed as well as or better than models using both 
basic and combined variables.  For RSV, the use of both clinical variables as well as 
concepts identified in HPIs resulted in a model that showed better discrimination than 
either basic or MetaMap model alone. 
As MetaMap concepts were found to be predictive for RSV test results, we 
explored the resulting tree produced by the J48 decision tree algorithm.  The tree is 
shown in Figure 7.  At the root node, the term “acute otitis media” identifies the first 
branch point, where inclusion of the term in an HPI was classified as positive by the 
model.  This node was followed by the term “bronchiolitis,” where again, inclusion of the 
word resulted in a positive classification.  The presence of the “cough” concept split the 
tree into two branches, where presence of the concept along with confirmation of “no 
rhinorrhea” resulted in a negative classification.  The presence of “cough” with 
“rhinorrhea” resulted in a positive classification.  On the other branch, the lack of 
“cough” was followed by whether the concept of “fever with cough” was present.  
Presence of “fever with cough,” “rhinorrhea,” and “crackles” resulted in a positive 
classification.  “Fever with cough” without mention of “rhinorrhea” also led to positive 
classifications.  Finally, the presence of “fever with cough” along with “rhinorrhea” 
without mention of “crackles” or “URI” resulted in a positive classification. 
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To determine how the MetaMap terms factor into the combined model for RSV, 
we mapped out the decision tree of the combined model (Figure 8).  Age was determined 
to be the first branching point, where patients less than 5.67 were deemed positive.  
Patients older than this age were then considered based on the season of their 
presentation.  Cases during the spring were classified as negative.  During the summer, if 
patients were > 14.33 years old, they were labeled as positive; otherwise, summer tests 
were negative.  During the fall, the model considered whether the concept “fever with 
cough” was present in the HPI and if so, the case was labeled positive.  Otherwise, the 
tree evaluated the patient’s age and if it was greater than 10.06, the patient was classified 
as positive.  The model evaluated cases during the winter first by whether “cough” or 
“fever with cough” were present.  If so, the case was labeled as positive.  If neither term 
was found in the HPI, the model evaluated the patient’s age, which if greater than 18.17, 
was classified as positive. 
We evaluated the each of the combined models for each of the viruses by calculating the 
sensitivity, specificity, positive predictive value (PPV) and negative predictive value 
(NPV), as shown in Table 3.  Because of the trade-off between sensitivity and specificity, 
we sought a target sensitivity of 95% for each of the models, as a sensitivity of 100% 
would yield 0% specificity and a lower sensitivity would potentially miss positive cases.  
Given the specifics of the decision tree algorithm, this target could not be achieved for all 
models, namely for rhinovirus, where sensitivity reached 94.3% before increasing to 
100%.  As detailed in Table 3, specificity ranged from 3.7% to 45.5% for all of the 
models at a sensitivity > 95% (except for rhinovirus).  Models for adenovirus and 
rhinovirus showed the lowest specificities, in the single digits.  While the PPV ranged 
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from 50.1% to 64.7% for all models, the NPV ranged from 52.1% to 100%.  For 
influenza, parainfluenza, RSV, and hMPV, the NPV was above 80.7%.  
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DISCUSSION 
This retrospective study evaluated respiratory virus testing performed in the 
general pediatric population at a tertiary academic children's hospital.  Over a quarter of 
all respiratory virus tests ordered were attributable to the pediatric population.  Of the 
tests that were ordered, the vast majority resulted in a negative finding.  Although we did 
not study the correlation of testing with changes in management (i.e. decreased antibiotic 
use, fewer studies ordered, or decreased cost of hospitalization), we found that no 
statistically significant difference in the lengths of stay of the various possible viral 
diagnoses, even where the result was negative.  In addition to a lack of clear guidelines 
that outline changes in management based on test results (except for influenza), our study 
calls into question the clinical utility of a positive result, as well as the basis of routine 
testing.   
Our objective was to develop a clinical model using information available at the 
time of test ordering that might reduce test volume, while ensuring that patients with 
detectable infections are still tested.  This study found that predictive models built on 
clinical variables were able to discriminate positive from negative better than chance.  
For 4 out of 6 viruses included in our study, billing data alone (age, season, gender) could 
be used to build models with fair predictive ability.  We also hypothesized that concepts 
contained in the HPI portion of the clinician’s admission documentation could improve 
the predictive ability of our models.  The precision of our concept matches via MetaMap 
were in line with previously published results (94–96).  In the case of RSV, a model 
based only on concepts in the HPI had the same predictive power as the model based on 
billing data.  Combining these two sources of data improved prediction of RSV.  Our 
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findings suggest a useful role for admission notes, aside from documentation. 
In the MetaMap-based model for RSV, our approach identified terms that fit the 
clinical representation of an RSV infection, supporting the validity of our methodology.  
The terms, particularly “bronchiolitis,” made intuitive sense for the diagnosis of RSV.  
One term that was somewhat surprising to us was the inclusion of “acute otitis media” as 
the root node of the tree.  Previously published literature has identified acute otitis media 
as a frequent complication following RSV infection (97–102).  However, only one study 
was found that suggests acute otitis media may present prior to to an RSV infection 
(103).  While further investigation is required, these results suggest that concept mapping 
in clinical notes has the potential to reveal new or understudied risk factors. 
Effective implementation of these models as screening tests requires practical 
understanding of the test characteristics as they relate to an institution’s clinical goals.  
The false negative rate may be an important measure, as care providers may assign a 
negative utility to a missed positive case.  As a result, a high sensitivity may be a highly 
valued attribute of a clinical model.  However, there exists a tradeoff with clinical models 
in which sensitivity and specificity are usually inversely related.  Therefore, a sensitivity 
of too high a value may yield a model that does not discriminate between positive and 
negative cases.  In this way, the specificity of the model has a large effect on cost, as it 
the measure that informs a decision maker that a test would likely yield a negative result.  
A model with increased specificity means that fewer patients, who would otherwise test 
negative, would actually receive DFA or PCR testing.  By limiting the number of disease 
negative patients who receive diagnostic testing, the population receiving diagnostic 
testing would be enriched for positive cases. Therefore a practical, cost-saving clinical 
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model would have the highest possible sensitivity to ensure a low false negative rate.  
Any model specificity above 0 would be safe and cost-effective without negative effects 
on care, compared to current practice.   
It is important to note that the presented clinical models are not designed to 
predict positive cases with high accuracy.  While we sought models that resulted in the 
highest sensitivities, these models often had very high false positive rates.  Thus, in our 
models, the “positive” and “negative” labels should be considered to be labels 
designating “high risk for positive result” and “low risk for positive test result.”  The 
distinction is important to the proposed function of the models, as the models were 
intended to aid the practitioners in reducing the number of overall tests that they order.  
In this way, for this project, models were considered to be helpful if they could achieve 
high sensitivity and any amount specificity.  Sacrificing sensitivity for specificity would 
result in fewer tests that might be ordered, but would also result in many more positive 
test results that would have been missed. 
From a practical point of view, clinical models could act as an “in silico” 
screening test for whether or not patients should receive testing.  If the models can be 
validated against a prospective dataset, they might find practical application via 
integration into the electronic medical record, running in the background as the clinician 
is entering data about a patient.  At the time of test ordering, the physician would be 
presented with information regarding what tests are likely negative or potentially 
positive.  The use of basic variables, as well as documented clinical symptoms, can 
reduce test volume for certain tests by up to nearly half with a low false negative rate.  
Future work will focus on validating the models, refining the text mining approach and 
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concept identification and implementing the information from the models into the 
clinician’s decision making pathway, as well as exploring the concept of customized 
panels, based on the prediction results of the models.     
 Our study has several limitations.  First, the population under study included only 
patients who received respiratory virus testing and selection criteria were not based on 
diagnostic codes.  As a result, the seasonal prevalence of disease may not be reflective of 
the true prevalence of viral infections.  Second, because of our numerous exclusion 
criteria, the models may not be generalizable beyond general pediatric inpatients.  Third, 
while the billing data are true independent variables, the variables collected by text 
mining with MetaMap may not be fully independent.  Because the timing of when 
admission notes were written could not be controlled, there is the possibility that some 
notes may have been written after test results were communicated.  We took several 
measures to prevent this, including selecting the oldest admission note on record and 
manually reviewing notes for mention of testing.   In addition, the retrospective nature of 
the study also prevented a comprehensive chart review with regard to the variables used 
in our models.  Instead, concepts from HPI text were recorded as “mentioned” versus 
“unmentioned.”  Because of the nature of the study, we were unable to conduct a 
prospective validation of our models, which would allow for perhaps a more accurate 
assessment of performance.  Our study also did not differentiate between different strains 
of viruses, which some of the tests are able to do (i.e. influenza A and B, parainfluenza 1-
3). 
The results presented here offer a new perspective on analyzing test utilization 
practices for respiratory viruses using data mining and natural language processing 
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techniques.  We find that in a tertiary academic children’s hospital, the majority of 
respiratory virus testing returns negative.  Furthermore, our results suggest that additional 
clinical factors may be used in a clinical model to predict the likelihood of an infection 
and the need for further diagnostic testing.  Text mining of clinical notes may augment 
the predictive power of future models, as demonstrated in our models of RSV.  This work 
contributes to the growing body of evidence that diverse forms data in the electronic 
medical record, not just billing data, can be used productively to build models that aid 
physicians in decision making.    
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Figure 1. The graphic depicts the study population with inclusion criteria.  From all 
of the respiratory virus test orders placed during this period, we identified pediatric 
patients who had not been hospitalized in the NNICU since birth.  Tests from inpatient 
visits, lasting less than 100 days were then selected.  To prevent the selection of 
nosocomial cases, we selected cases where testing was performed within a short window 
following admission.  From this, we selected cases where an adequate NP sample had 
been collected.  Visits where an admission note was available were included for the final 





Figure 2. Boxplots of the lengths of stay are similar for all possible virus diagnoses.  
The median length of stay for diagnoses of adenovirus (n = 32), influenza (n = 40), 
parainfluenza (n = 93), RSV (n = 234), rhinovirus (n = 180), co-infection (n = 57), and 
non-detected viruses (n = 1519) is 2 days. The median length of stay for a diagnosis of 
human metapneumovirus (n = 29) is 3 days.  The dark horizontal lines represent the 
median with the box representing the 25th and 75th percentiles.  The whiskers depict the 





Figure 3.  Ordering of respiratory test panels throughout the year.  (A) total number 
of ordered DFA panels by month; (B) total number of ordered PCR panels by month. 
Note that the y-axis for the panels differ, as DFA panels are ordered in greater volume 





Figure 4. Positive test results as a proportion of all test result for each detectable 
virus, by month. Each line represents the pattern of positive test results for each virus, 
where each point is the monthly proportion of positive results over all positive tests 





Figure 5. J48 decision tree classifier models predicting whether a panel of tests 
(DFA or PCR) will contain one positive result.  A cost sensitive classifier was used as 
a wrapper for the J48 decision tree classifier to weight against false negative cases.  
Models were designed to discriminate between panels containing at least one positive test 
result versus all negative test results.  The varying lines represent different sources of 
data use to generate the models.  Lines in red represent “basic” models derived from 
administrative billing data that predict the outcome for DFA (AUC = 0.523) and PCR 
(AUC = 0.601) panels.  Lines in blue represent “MetaMap” models using concepts 
identified by the MetaMap software only to predict the outcome for DFA (AUC = 0.624) 
and PCR (AUC = 0.576) panels.  Lines in green represent “combined” models that use 
both administrative billing data and MetaMap concepts for DFA (AUC = 0.671) and PCR 
(AUC = 0.628) panel prediction. 
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Figure 6. J48 decision tree classifier models predicting the outcome of laboratory 
tests for individual viruses.  Models were designed to discriminate positive versus 
negative test results for each virus.  A cost sensitive classifier was used as a wrapper for 
the J48 decision tree classifier to weight against false negative cases.  The varying lines 
represent different sources of data use to generate the models.  The performance 





Figure 7. Graphical depiction of the RSV decision tree generated by the J48 
classifier model using only MetaMap concepts.  Using the tree, each case begins with 
the presence (bolded double line) or absence (dashed line) of the term “acute otitis 
media” in the physician’s history of present illness, passes through the subsequent nodes 
in a similar manner, and depending on the concepts contained in the HPI, ends in 
terminal leaves, marked “positive” and “negative”.   
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Figure 8. The graphical representation of the J48 decision tree classifier for RSV 
when based on both administrative billing data and MetaMap concepts.  Thresholds 
for administrative billing data (age and season) were determined by the J48 algorithm 
based on the information gain provided by the resulting attribute splits.  These are 
denoted by the single lines.  The presence or absence of terms in the clinician HPIs are 








































































































































































































































































































































































































































































































Table 2. Receiver operator characteristic curve characteristics 
 ROC curve AUC (SE) 
 Basic model MetaMap model Combined model 
Adenovirus 0.568 (0.114) 0.480 (0.099) 0.532 (0.108) 
Influenza 0.743 (0.126) 0.451 (0.084) 0.715 (0.122) 
Parainfluenza 0.686 (0.078) 0.510 (0.061) 0.694 (0.078) 
RSV 0.658 (0.048) 0.661 (0.048) 0.722 (0.051) 
hMPV 0.713 (0.143) 0.474 (0.103) 0.682 (0.138) 
Rhinovirus 0.549 (0.047) 0.471 (0.041) 0.570 (0.048) 
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Table 3. Test characteristics of combined model for each of the viruses 
Virus Sensitivity Specificity PPV NPV 
Adenovirus 0.966 0.037 0.501 0.521
Influenza 1.00 0.455 0.647 1.00
Parainfluenza 0.965 0.198 0.546 0.850
RSV 0.953 0.196 0.542 0.807
hMPV 0.974 0.205 0.551 0.887
Rhinovirus 0.943 0.076 0.505 0.571
*A minimum threshold sensitivity of 95% was set for each of the combined models. 
 
 
